MIT SCIENTIFIC, INC.

MIT Scientific, Inc. commits to building practitioner-sourced legendary medical devices through a state-of-the-art facilitator platform in the fields of Interventional Cardiology, Endovascular, Structural Heart, and Interventional Neuroradiology. With its platform approach it closes the gap between grassroot-sourced medical device innovations and a seamless transformation into effective, commercially viable tools for practitioners. A long overdue exercise. MIT Scientific operates as a MedTech ... holding that invests in SPV’s dedicated to the development of insourced IP’s. This structure maximizes the term-sheet flexibility for each investment, increases profitability, minimize a broad range of risks and allows for faster exits for both MIT Scientific and eventual SPV co-investors, while benefitting from the expertise and resources of the holding all way through. MIT Scientific is founded by Rafal W. Lopallo, a self-made, value and values driven entrepreneur in the medical device industry. Thanks to his reputation, the company brings together a team of renowned industry experts to ensure a value chain, driven by a culture of excellence. The time for a facilitator platform is right for both, innovators and investors while bringing to life novel medical device. For initially onboarding two devices, and kicking off the holding, MIT Scientific is seeking to raise USD 1.54 million in a first financing round, with VC partners that recognize and appreciate the impact MIT will create.